Stephanie M. Cash
Associate
Stephanie Cash advises clients in a wide range of corporate matters, including corporate and commercial contracts, supply chain contracts, corporate governance, SEC compliance and disclosure, stock exchange listing requirements, and fiduciary duties of officers and directors.
A member of Foley’s Transactions Practice Group and Supply Chain Industry Team, Stephanie is also experienced in the representation of a variety of public and private companies in mergers, acquisitions, and business reorganizations. She is a regular author and editor of thought leadership for Foley’s Manufacturing Industry Advisor blog, where she discusses key topics in the sector with an emphasis on supply chain disruption.
Contract Manufacturing Primer for Emerging Healthy F&B Companies
A contract manufacturer is a critical partner for most emerging companies in the healthy food and beverage space.
Three Key Defenses to Contractual Performance: Force Majeure, Commercial Impracticability, and Frustration of Purpose
As part of our ongoing Supply Chain Disruption Series, we examine 3 key defenses to ward off breach of contract claims relating to delays or non-delivery.
At What Price?: Pricing Strategies to Deal with Rising Costs
Given the rapidly changing supply chain landscape, how can a supplier address its rising costs in its pricing to its customers?
Foley Featured in Global Legal Chronicle for Advising Aspirus, Inc.
Foley & Lardner was featured in a Global Legal Chronicle article entitled, “Aspirus’ Acquisition of Seven Hospitals, 21 Physician Clinics, and Air and Ground Medical Transport Services,” detailing the transaction between Aspirus, Inc. and Ascension Wisconsin.
Foley Advises Aspirus, Inc. in Acquisition of Seven Hospitals, 21 Physician Clinics, and Air and Ground Medical Transport Services
Foley & Lardner LLP acted as corporate/deal counsel to Aspirus, Inc., in its assumption of ownership from Ascension Wisconsin of seven hospitals, 21 physician clinics, and air and ground medical transport services.
Rethinking China: How Manufacturers are Analyzing Right-Shoring to Consider the Benefits and Costs of a Shift in Supply Chains
Even before COVID-19, companies were considering whether China continued to make sense for their offshore manufacturing operations.